Format

Send to

Choose Destination
See comment in PubMed Commons below
Biochem Biophys Res Commun. 2001 Oct 5;287(4):977-82.

Truncation of WT1 results in downregulation of cyclin G1 and IGFBP-4 expression.

Author information

1
Sir Alastair Currie CRC Laboratories, Molecular Medicine Centre, University of Edinburgh, Western General Hospital, Crewe Road, Edinburgh EH4 2XU, United Kingdom.

Erratum in

  • Biochem Biophys Res Commun 2001 Oct 26;288(2):493.

Abstract

Mutations in the WT1 gene are found in a subset of Wilms' tumours and in certain other disorders such as Denys-Drash syndrome. The WT1 gene product is a zinc finger transcription factor for which many target genes have been suggested. Here we utilise gene targeting to generate cells containing only truncated forms of WT1, in which the DNA-binding region is disrupted. Examination of gene expression in these cells using cDNA macroarrays suggests two novel WT1 transcriptional targets, cyclin G1 (Ccng1), and insulin-like growth factor binding protein 4 (Igfbp4).

PMID:
11573961
DOI:
10.1006/bbrc.2001.5693
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center